
Suven Pharmaceuticals Share Price
₹1,226.45 +15.25 (1.26%)
22 Feb, 2025 22:47
Start SIP in
SUVENPHAR
Performance
- Low
- ₹1,176
- High
- ₹1,232
- 52 Week Low
- ₹598
- 52 Week High
- ₹1,360
- Open Price₹1,204
- Previous Close₹1,211
- Volume534,701
Investment Returns
- Over 1 Month + 16.39%
- Over 3 Month -3.77%
- Over 6 Month + 20.17%
- Over 1 Year + 83.49%
Smart Investing Starts Here Start SIP with Suven Pharmaceuticals for Steady Growth!
Suven Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 111.8
- PEG Ratio
- -4.5
- Market Cap Cr
- 31,221
- P/B Ratio
- 15.8
- Average True Range
- 69.25
- EPS
- 10.97
- Dividend Yield
- 0
- MACD Signal
- 6.37
- RSI
- 64.29
- MFI
- 85.79
Suven Pharmaceuticals Financials
Suven Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,226.45
+
15.25
(1.26%)

-
- Bullish Moving Average 16
-
- Bearish Moving Average 0
- 20 Day
- ₹1,122.83
- 50 Day
- ₹1,126.30
- 100 Day
- ₹1,124.51
- 200 Day
- ₹1,043.38
Resistance and Support
1211.52
- R3 1,303.73
- R2 1,268.02
- R1 1,247.23
- S1 1,190.73
- S2 1,155.02
- S3 1,134.23
Suven Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Suven Pharmaceuticals F&O
About Suven Pharmaceuticals
- NSE Symbol
- SUVENPHAR
- BSE Symbol
- 543064
- Managing Director
- Dr. V Prasada Raju
- ISIN
- INE03QK01018
Similar Stocks to Suven Pharmaceuticals
Suven Pharmaceuticals FAQs
Suven Pharmaceuticals share price is ₹1,226 As on 22 February, 2025 | 22:33
The Market Cap of Suven Pharmaceuticals is ₹31221.1 Cr As on 22 February, 2025 | 22:33
The P/E ratio of Suven Pharmaceuticals is 111.8 As on 22 February, 2025 | 22:33
The PB ratio of Suven Pharmaceuticals is 15.8 As on 22 February, 2025 | 22:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.